Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.39 USD | +9.63% | +22.56% | +18.91% |
Apr. 15 | Top Premarket Decliners | MT |
Jan. 30 | Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023 | CI |
Financials (USD)
Sales 2022 | 40.14M | Sales 2023 | 32.31M | Capitalization | 3.46M |
---|---|---|---|---|---|
Net income 2022 | -8M | Net income 2023 | -6M | EV / Sales 2022 | -0.07 x |
Net cash position 2022 | 14.92M | Net cash position 2023 | 13.02M | EV / Sales 2023 | -0.3 x |
P/E ratio 2022 |
-1.41
x | P/E ratio 2023 |
-0.56
x | Employees | 225 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 42.95% |
1 day | +9.63% | ||
1 week | +22.56% | ||
Current month | +9.13% | ||
1 month | +9.13% | ||
6 months | +109.65% | ||
Current year | +18.91% |
Managers | Title | Age | Since |
---|---|---|---|
Gang Lai
CEO | Chief Executive Officer | 56 | - |
Lin Yang
DFI | Director of Finance/CFO | 48 | - |
Baochang Liu
COO | Chief Operating Officer | 44 | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gang Lai
CEO | Chief Executive Officer | 56 | - |
Lin Yang
DFI | Director of Finance/CFO | 48 | - |
Jiawen Pang
BRD | Director/Board Member | 57 | 21-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 2.39 | +9.63% | 52,850 |
24-04-26 | 2.18 | -5.63% | 20,020 |
24-04-25 | 2.31 | +7.74% | 147,492 |
24-04-24 | 2.144 | -2.54% | 35,261 |
24-04-23 | 2.2 | +12.82% | 52,257 |
Delayed Quote Nasdaq, April 29, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+18.91% | 8.66M | |
+37.08% | 6.01B | |
-17.43% | 4.4B | |
-9.46% | 3.17B | |
+0.51% | 3.07B | |
-3.53% | 2.51B | |
+41.15% | 1.88B | |
-5.15% | 1.73B | |
+0.09% | 1.65B | |
-10.38% | 1.58B |
- Stock Market
- Equities
- UPC Stock